Efficacy and safety of vena cava filters in preventing pulmonary embolism: A systematic review and meta-analysis.

Autor:	Miao HT; Center for Cononary Artery Disease, Beijing Anzhen Hospital, Capital Medical Universisty, Beijing, China., Li XY; Department of Health Care for Cadres, Beijing Jishuitan Hospital, Beijing, China., Zhou C; Center for Cononary Artery Disease, Beijing Anzhen Hospital, Capital Medical Universisty, Beijing, China., Liang Y; Emergency & Critical Care Center, Beijing Anzhen Hospital, Capital Medical University, Beijing, China., Nie SP; Center for Cononary Artery Disease, Beijing Anzhen Hospital, Capital Medical Universisty, Beijing, China.
Jazyk:	angličtina
Zdroj:	Phlebology [Phlebology] 2023 Aug; Vol. 38 (7), pp. 474-483. Date of Electronic Publication: 2023 Jun 21.
DOI:	10.1177/02683555231185649
Abstrakt:	Objectives: To assess the treatment effectiveness of inferior vena cava filters (IVCF) versus non-IVCF for patients undergoing varies conditions. Methods: We systematically searched the databases to identify eligible RCTs from their inception up to 9/20/2020. The primary endpoint was pulmonary embolism (PE), while the secondary endpoints included deep-vein thrombosis (DVT), major bleeding, and all-cause mortality. The RRs with 95% CIs were applied as effect estimates for the treatment effectiveness of IVCF versus non-IVCF and calculated by using the random-effects model. Results: 1,137 patients of 5 RCTs were enrolled. There were no significant differences between IVCF and non-IVCF for the risk of PE, major bleeding, and all-cause mortality, while the risk of DVT was significantly increased for patients treated with IVCF. Conclusions: The use of IVCF did not yield any benefits on PE, major bleeding, and all-cause mortality risk for patients undergoing various conditions, while the risk of DVT was significantly increased for patients treated with IVCF.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu